Nature Research, Nature Medicine, 10(17), p. 1183-1185, 2011
DOI: 10.1038/nm.2493
Full text: Download
BRCA1 germline mutations lead to an increased risk of breast and ovarian cancer, but the mechanisms by which the product of this gene functions as a tumor suppressor have remained elusive. Now, analysis of a missense BRCA1 variant shows that it can epigenetically regulate an miRNA implicated in cancer, providing new mechanistic insights (pages 1275-1282).